Abstract: The invention relates to a clear, cosmetic and dermatological formulation having reduced stickiness, comprising at least one antiperspirant active ingredient and/or deodorant active ingredient, at least one ?-hydroxycarboxylic acid and water.

Abstract: A process for producing a compressed solid dosage form containing an active ingredient. The process includes a step of preparing core elements containing the active ingredient. Optionally the core elements are coated with a pharmaceutically acceptable coating layer to form coated pellets. The core elements or pellets are treated with an anti-static agent and compressed with suitable excipients to form the compressed solid dosage form. Preferred anti static agents are starch, microcrystalline cellulose, kaolin, bentonite, silicates, silicon dioxide, cellulose, stearic acid, sodium stearyl fumarate and glyceryl behenate.

Abstract: Interleukin-10 (IL-10) conjugated via a linker to one or more polyethylene glycol (PEG) molecules at a single amino acid residue of the IL-10, and a method for preparing the same, are provided. The method produces a stable mono-pegylated IL-10, which retains IL-10 activity, where pegylation is selective for the N-terminus on one subunit of IL-10 with little or no formation of monomeric IL-10. The method also provides a substantially homogenous population of mono-PEG-IL-10.

Abstract: Polycondensate, composition containing it, especially a nail varnish composition, and process for preparation. The polycondensate may be obtained by reacting: a polyol comprising 3 to 6 hydroxyl groups; a saturated or unsaturated non-aromatic monocarboxylic acid; an aromatic monocarboxylic acid containing 7 to 11 carbon atoms; and a saturated or unsaturated, or even aromatic, linear, branched and/or cyclic polycarboxylic acid, comprising at least two carboxylic groups COOH; and/or a cyclic anhydride of such a polycarboxylic acid.

Abstract: A hair cosmetic composition, containing the following Components (A) to (E): (A) benzyl alcohol, from 0.1 to 2% by mass; (B) dipropylene glycol, from 0.5 to 20% by mass; (C) malic acid or a salt thereof, from 0.2 to 10% by mass, in terms of the malic acid; and (D) lactic acid or a salt thereof, from 0.2 to 10% by mass, in terms of the lactic acid; and (E) a nonionic surfactant at 2% by mass or less, wherein a Component (E)/Component (A) mass ratio is from 0 to 5, and wherein a Component (B)/Component (A) mass ratio is from 1 to 50.

Abstract: The present invention is directed to a series of polymeric glyceryl esters that have two different molecular weight ester chains, one solid and one liquid, which when combined into a single molecule make a polymer that is solid, and crosslinked by dimer acid. These products have very unique skin feel and water proofing properties. These materials find applications as additives to formulations in personal care products where there is a desire to have a structured film (provided by the solid fatty group) and flow properties, (provided by the liquid fatty group). These compounds by virtue of their unique structure provide outstanding skin feel.

Abstract: A fat emulsion comprises a prostaglandin as an active ingredient, the fat emulsion comprising a phospholipid that comprises phosphatidylcholine (PC) and phosphatidylglycerol (PG) and has a ratio of PC to PG (PC:PG) of 85:15 to 99.7:0.3.

Abstract: The invention relates to alkyl benzoate mixtures, the sum of the C12- and C14-alkyl benzoates being greater than or equal to 85%, in relation to the total sum of the alkyl benzoates. The invention also relates to the use of said alkyl benzoate mixtures in cosmetic and/or pharmaceutical preparations, in particular as oil components.

Abstract: A nail varnish additive contains a) at least one silane of the general formula wherein the radicals R1, R2, R3, R4 are identical or different, have 1 to 40 carbon atoms and are non-crosslinking, and optionally b) at least one solvent.

Abstract: A hair cosmetic composition, containing the following Components (A) to (D): (A) benzyl alcohol, from 0.1 to 2% by mass; (B) dipropylene glycol, from 0.5 to 20% by mass; (C) malic acid or a salt thereof, from 0.2 to 10% by mass, in terms of the malic acid; and (D) lactic acid or a salt thereof, from 0.2 to 10% by mass, in terms of the lactic acid; and optionally containing a surfactant (E) at a concentration of 2% by mass or less and at a Component (E)/Component (A) mass ratio falling within a range of from 0 to 5.

Abstract: The present invention relates to an aqueous polymer dispersion which is obtainable by free-radical polymerization of a monomer mixture which comprises at least one amide-group-containing compound, at least one crosslinker and at least one monomer with at least one cationogenic and/or cationic group. The invention further relates to the polymers obtainable by drying such a polymer dispersion, and to cosmetic or pharmaceutical compositions which comprise such a polymer dispersion or such a polymer.

Abstract: A pellet or pellets having an average particle size in the range from 300 to 1,100 ?m, comprising a pharmaceutically active substance embedded in a polymer matrix of one or more water-insoluble polymers, wherein the polymer matrix additionally contains 10 to 90% by weight of an anionic polymer and with the proviso that the pellets release no more than 10% of the active compound contained in the release test according to USP in artificial gastric juice at pH 1.2 after 120 min and release at least 50% of the active compound contained after altogether a further 300 min at pH 6.8 and/or pH 7.5.

Abstract: Disclosed are polymers of hydroxypropyl methyl cellulose acetate succinate (HPMCAS) and hydroxypropyl methyl cellulose acetate (HPMCA) with unique degrees of substitution of hydroxypropoxy, methoxy, acetyl, and succinoyl groups. When used in making compositions comprising a low-solubility drug and such polymers, the polymers provide enhanced aqueous concentrations and/or improved physical stability.

Abstract: A shampoo formulation comprising a shampoo, bicarbonate soda, and onion skins used alone or in combination with a conditioner comprising acetic acid for the treatment of hair loss and promotion of hair growth.

Abstract: The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present topical formulations encompass a non-flammable solvent for malathion effective in killing head lice. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.

Abstract: An object of the present invention is to provide a medical agent that has an excellent effect on the diseases resulting from one of inflammation and remodeling and that can prevent or treat them in response to various mechanisms of onset and development of the diseases. Thus, the present invention relates to a medical agent for preventing or treating diseases resulting from one of inflammation and remodeling in blood vessel, including nanobubbles.

Abstract: A solid deodorizer (14) for use on the inside surface (12) of an ostomy pouch (10). The solid deodorizer include a deodorizing mixture (24) and a carrier (16) by which the deodorizer is attached to the inside of the pouch. The carrier has filaments (22) which are molded into the mixture, and an adhesive (20). The deodorizing mixture includes activated charcoal, glycerin, and wax, and may include one or more of sodium bicarbonate, stearic acid, and/or starch.

Abstract: Disclosed is a process for the preparation of sterile aqueous suspensions based on active ingredients in the form of micronised crystalline particles designed for administration by inhalation. In particular, a process for the preparation of sterile aqueous suspensions based on pharmaceutical active ingredients in the form of crystalline hydrates is disclosed.

Abstract: The present invention provides an herbicidal method for selective post-emergence control of broadleaf weeds by applying a synergistic herbicidal composition, wherein the composition comprises a mixture of sulfentrazone and metsulfuron methyl.

Abstract: The present invention provides an herbicidal method for selective pre- and post-emergence control of broadleaf and grass weeds by applying a synergistic herbicidal composition, wherein the composition comprises a mixture of sulfentrazone and dithiopyr.